You have 8 free searches left this month | for more free features.

HR HER2- Breast Cancer

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Carcinoma Trial in Copenhagen (Partial breast irradiation, Whole breast irradiation)

Active, not recruiting
  • Breast Carcinoma
  • Partial breast irradiation
  • Whole breast irradiation
  • Copenhagen, Copenhagen Ø, Denmark
    The Danish Breast Cancer Cooperative Group
Feb 24, 2020

Breast Cancer, Tumors, Breast, Cancer Screening Trial in Royal Oak, Pittsburgh (FFDM, DBT)

Completed
  • Breast Cancer
  • +2 more
  • FFDM
  • DBT
  • Royal Oak, Michigan
  • +1 more
Jan 27, 2019

Recurrent/Metastatic Breast Cancer Trial in Changchun (TQB3616 Capsule)

Completed
  • Recurrent/Metastatic Breast Cancer
  • TQB3616 Capsule
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Apr 18, 2022

Necrotizing Fasciitis, Fournier Gangrene, Necrotizing Soft Tissue Infection Trial in Créteil (non interventional)

Recruiting
  • Necrotizing Fasciitis
  • +2 more
  • non interventional
  • Créteil, France
    Hopital Henri Mondor
Nov 22, 2021

Urinary Bladder Cancer Trial in Tucson (Gemcitabine)

Not yet recruiting
  • Urinary Bladder Cancer
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 21, 2022

Ovarian Cancer Trial in Worldwide (Prexasertib)

Completed
  • Ovarian Cancer
  • Tucson, Arizona
  • +45 more
Sep 28, 2021

Stratification for pT4bN0M0 Colorectal Cancer Following

Completed
  • Colorectal Cancer
  • multivisceral resection
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Oct 30, 2023

Heart Failure, Cardiotoxicity, Cancer Trial (Cardio-oncology Rehabilitation (CORE), PAI Group (PAI), Exercise Guidelines for

Not yet recruiting
  • Heart Failure
  • +2 more
  • Cardio-oncology Rehabilitation (CORE)
  • +2 more
  • (no location specified)
Aug 19, 2021

Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • (no location specified)
Dec 5, 2022

Prostate Cancer Trial in France (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • Angers, France
  • +37 more
Jan 17, 2023

Chronic Pain, Cancer Pain Trial in New York (MORE treatments, Standard of Care for Pain Management)

Recruiting
  • Chronic Pain
  • Cancer Pain
  • MORE treatments
  • Standard of Care for Pain Management
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
May 17, 2023

Breast Cancer Trial in Canada, United States (cyclophosphamide, doxorubicin HCl, paclitaxel)

Completed
  • Breast Cancer
  • Scottsdale, Arizona
  • +18 more
Apr 28, 2020

ArtiSential in Colorectal Cancer Surgery Using Prospectively

Recruiting
  • Rectal Cancer
  • +2 more
  • ArtiSential
  • Seoul, Korea, Republic of
    Samsung Medical Center
Oct 4, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023

Lymphoma Trial (Fatigue Reduction Diet, General Health Curriculum)

Not yet recruiting
  • Lymphoma
  • Fatigue Reduction Diet
  • General Health Curriculum
  • (no location specified)
Sep 14, 2023

Insomnia, Insomnia Due to Medical Condition, Cancer Trial in Boston (STEP-YA with Coaching, STEP-YA without Coaching)

Recruiting
  • Insomnia
  • +2 more
  • STEP-YA with Coaching
  • STEP-YA without Coaching
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 12, 2022

sCD8, as a Novel Biomarker for Pancreatic Cancer

Recruiting
  • Serum Biomarker
  • Pancreatic Cancer
  • serum test
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 11, 2022

Breast Cancer, Breast Tumors Trial in Uden (Adherence Improving self-Management Strategy, Regular care)

Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Adherence Improving self-Management Strategy
  • Regular care
  • Uden, Netherlands
    Bernhoven
Jan 18, 2021

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Cancer Trial in Indianapolis, Pittsburgh, Memphis (MAAT-YS)

Not yet recruiting
  • Cancer
  • MAAT-YS
  • Indianapolis, Indiana
  • +2 more
Nov 27, 2023

Male Breast Cancer Trial in Groningen (AndroGel)

Not yet recruiting
  • Male Breast Cancer
  • Groningen, Netherlands
    UMCG
May 17, 2022

Advanced Lung Cancer Trial in Hangzhou (WTX212A injection)

Not yet recruiting
  • Advanced Lung Cancer
  • WTX212A injection
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Oct 27, 2023

Tumors Trial in Strasbourg (Advance Care Planning Intervention)

Not yet recruiting
  • Neoplasms
  • Advance Care Planning Intervention
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Nov 20, 2023

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +21 more
  • Atezolizumab
  • +8 more
  • Little Rock, Arkansas
  • +97 more
Jan 27, 2023

Colorectal Cancer, Liver Metastases Trial (QBECO, Placebo)

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • (no location specified)
Jan 6, 2023